Tempus AI (NASDAQ:TEM) Shares Down 0% on Insider Selling

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s share price fell 0% during trading on Thursday following insider selling activity. The company traded as low as $47.12 and last traded at $48.02. 3,016,581 shares were traded during trading, a decline of 40% from the average session volume of 5,007,310 shares. The stock had previously closed at $48.03.

Specifically, Director David R. Epstein sold 990 shares of Tempus AI stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $46.83, for a total value of $46,361.70. Following the transaction, the director now directly owns 26,284 shares of the company's stock, valued at $1,230,879.72. The trade was a 3.63 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Andrew Polovin sold 13,135 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $45.98, for a total value of $603,947.30. Following the sale, the executive vice president now owns 154,171 shares in the company, valued at approximately $7,088,782.58. This represents a 7.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In other news, CFO James William Rogers sold 23,030 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $45.97, for a total transaction of $1,058,689.10. Following the sale, the chief financial officer now directly owns 164,750 shares in the company, valued at approximately $7,573,557.50. The trade was a 12.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Remove Ads

Analyst Upgrades and Downgrades

TEM has been the topic of a number of research reports. Guggenheim restated a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Bank of America boosted their price objective on Tempus AI from $54.00 to $60.00 and gave the company a "neutral" rating in a research report on Monday, March 3rd. JPMorgan Chase & Co. lowered Tempus AI from an "overweight" rating to a "neutral" rating and boosted their price target for the company from $50.00 to $55.00 in a research note on Tuesday, February 25th. William Blair reaffirmed a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, Wolfe Research lowered Tempus AI from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Tempus AI currently has an average rating of "Moderate Buy" and an average target price of $61.18.

Tempus AI Trading Up 6.9 %

The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The business has a 50 day simple moving average of $56.35 and a 200 day simple moving average of $51.38.

Hedge Funds Weigh In On Tempus AI

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Wells Fargo & Company MN boosted its stake in Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after purchasing an additional 278 shares in the last quarter. First Horizon Advisors Inc. acquired a new position in Tempus AI in the third quarter worth $30,000. Geode Capital Management LLC raised its position in shares of Tempus AI by 0.4% during the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company's stock worth $7,537,000 after acquiring an additional 539 shares during the last quarter. Operose Advisors LLC bought a new stake in shares of Tempus AI during the fourth quarter worth $25,000. Finally, Prestige Wealth Management Group LLC raised its position in shares of Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after acquiring an additional 965 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.